McKesson Corp (MCK) company profile
Close on Nov 18, 2026Market cap $126.43BP/E 29.0Yield 0.29%
About McKesson
Wholesale-Drugs, Proprietaries & Druggists' Sundries, SIC 5122
McKesson Corporation is an enterprise involved in healthcare distribution and support services. Operating across distinct operating segments including North American Pharmaceutical, Medical-Surgical Solutions, Oncology and Multispecialty, and Prescription Technology Solutions, the company supplies pharmaceuticals, medical-surgical products, and specialized technology infrastructure. Its operations serve broad healthcare customers through established provider networks, distribution channels, and integrated care solutions across multiple clinical disciplines.
The text indicates business presence across North America and several international jurisdictions, citing operational activities and tax affiliations in Canada, the United Kingdom, Germany, and Luxembourg. The report details physical property, equipment, and network assets across domestic and overseas sites, alongside historical retail operations in Canada and Norway. The provided filing text does not disclose the city or state of the company's headquarters.
Summary of the business section of McKesson's latest annual report, written by StockData.
Company profile
Company
- Legal name
- McKesson Corp
- Founded
- 1833
- Headquarters
- Irving, TX
- Address
- 6555 State Highway 161 75039
- Phone
- (972) 446-4800
- Website
- www.mckesson.com
- Employees
- 43,000, Mar 31, 2026
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Incorporated in
- Delaware
- Fiscal year ends
- March 31
- Auditor
- Deloitte & Touche LLP, Dallas, Texas
Stock & identifiers
- Ticker
- MCK
- Exchange
- NYSE
- IPO date
- Nov 10, 1994
- Shares outstanding
- 117M, Jul 31, 2026
- Public float
- $95.30B, Sep 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 2-for-1, Jan 5, 1998
- SEC CIK
- 927653
- CUSIP
- 58155Q103
- ISIN
- US58155Q1031
- FIGI
- BBG000DYGNW7
- Share class FIGI
- BBG001S8F8P8
- LEI
- 549300WZWOM80UCFSF54
- EIN
- 94-3207296
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Brian S. Tyler | Chief Executive Officer, Director | 6,135 |
| Francisco Fraga | EVP, CIO and CTO | 4,414 |
| Napoleon B. Rutledge JR | SVP, Controller & CAO | 521 |
| Ramesh (NMN) Srinivasan | EVP and Chief Strategy Officer | 11,959 |
| Thomas L. Rodgers | EVP, Chief Strategy & BDO | 2,268 |
| LeAnn B. Smith | EVP & Chief HR Officer | 4,798 |
| Kenny K. Cheung | EVP & CFO | – |
| Michele Lau | EVP and Chief Legal Officer | 3,386 |
| Britt J. Vitalone | EVP & CFO | 22,506 |
| Bradley E. Lerman | Director | 0 |
| Kathleen Wilson-Thompson | Director | 578 |
| Kevin M. Ozan | Director | 15 |
| Lynne M. Doughtie | Director | – |
| Deborah Dunsire | Director | – |
| Maria Martinez | Director | 578 |
| Webster Roy Dunbar | Director | – |
| James H. Hinton | Director | – |
| Julie L. Gerberding | Director | – |
| Dominic J. Caruso | Director | 927 |
| Donald R. Knauss | Director | 2,069 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2026 | $24.21M | $48.93M | $5.49M | $456 | $137 |
| FY2025 | $20.16M | $39.17M | $4.96M | $353 | $134 |
| FY2024 | $19.00M | $51.71M | $5.20M | $281 | $133 |
| FY2023 | $20.22M | $38.81M | $4.90M | $185 | $115 |
| FY2022 | $18.15M | $65.28M | $4.51M | $158 | $119 |
| FY2021 | $14.84M | $33.05M | $4.27M | $146 | $134 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2026
Summary compensation table from the latest proxy statement
| Executive | Salary | Stock awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| Brian S. Tyler Chief Executive Officer | $1.59M | $17.20M | $4.46M | $963.51K | $24.21M | +20% |
| Britt J. Vitalone Executive Vice President and Chief Financial Officer | $1.06M | $5.60M | $1.86M | $209.82K | $8.74M | +14% |
| Michele Lau Executive Vice President and Chief Legal Officer | $766.58K | $3.65M | $1.07M | $104.87K | $5.60M | +7% |
| LeAnn B. Smith Executive Vice President and Chief Human Resources Officer | $693.83K | $2.50M | $971.37K | $87.93K | $4.25M | +14% |
| Thomas L. Rodgers Executive Vice President and Chief Strategy and Business Development Officer | $647.45K | $1.75M | $906.43K | $81.97K | $3.39M | +5% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“As of March 31, 2026, we had more than 43,000 employees worldwide, which includes 1,400 part-time employees.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?